Kay Benbow

Ask VT AI
View News Summary
  • Edison lowers FY2025 guidance, sending shares lower amid mixed sector performance.
  • Typhoon Kalmaegi batters the Philippines, causing evacuations, power outages, and rescue challenges.
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Edison lowers FY2025 guidance, sending shares lower amid mixed sector performance.
  • Typhoon Kalmaegi batters the Philippines, causing evacuations, power outages, and rescue challenges.
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Kay Benbow